$LLY Eli Lilly Q2 Earnings

05 Aug 2026 10:47US Stocks
  • Adj. EPS $8.38 vs. $6.31 y/y
  • Rev. $22.97B, est. $20.59B
  • Zepbound rev. $4.93B, est. $4.64B
  • Mounjaro rev. $9.9B, est. $8.83B
  • Trulicity rev. $1.22B, est. $868.8M
  • Humalog rev. $410M, est. $448.5M
  • Foundayo rev. $98M, est. $92M
  • Committed addl. $4.5B to expand manufacturing sites
  • Sees FY rev. $85.0B to $87.0B, saw $82.0B to $85.0B
  • Sees FY adj. EPS $35.50 to $36.50, saw $35.50 to $37
  • Raises year guidance
  • Easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro forecas